Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-27T03:30:36.687Z Has data issue: false hasContentIssue false

Characteristics of the handling of amisulpride in a brief internment unit

Published online by Cambridge University Press:  16 April 2020

A. Vispe
Affiliation:
Department of Psychiatry, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain
J.G. Valdecasas
Affiliation:
Department of Psychiatry, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain
D. Diaz
Affiliation:
Department of Psychiatry, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain
E. Diaz
Affiliation:
Department of Psychiatry, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain
M. Sangines
Affiliation:
Department of Psychiatry, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background and aims:

Knowing the use profile of amisulpride, as well as information about its effectiveness and resistance in our environment.

Methods:

Open and prospective study of a sample of 40 patients treated with amisulpride during their admission at hospital. We will note the following variables: age, sex, diagnosis, seriousness level in admission / discharge (measured through the BPRS scale), dose, concomitant medication, side effects, suspension reason, if any, and time at hospital.

Results:

We show the results of the studied variables, noticing the efficacy of the medicine in the symptomatological control of different disorders, specially schizophrenia. Furthermore, we have information about its resistance and about the medications, with what it is more frequently associated.

Conclusions:

We can conclude, on the basis of the obtained results, that amisulpride is effective and well resisted in the greater part of the cases.

Type
Poster Session 1: Antipsychotic Medications
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.